Skip to main content
Continuing Education - Continuing Professional Development for Today's Healthcare Professionals
  •  

Pancreatic Cancer Update


Scott Soefje, PharmD, MBA
Director, Pharmacy Cancer Care
Mayo Clinic Assistant Professor of Pharmacy
Mayo Clinic College of Medicine and Science
Learning Objectives
  • Examine briefly treatment approaches for pancreatic cancer.
  • Discuss challenges to treating this cancer.
  • Discuss opportunities for pharmacists to support patients with pancreatic cancer.

Activity Description

This program consists of 1 video and downloadable resources in PDF format.  To begin, take the ungraded pre-test for the module below.  Review the video and handout(s), then complete the post-test ( > 70% within 5 attempts) and evaluation. CPE credit will automatically upload to CPE Monitor (allow 7 days). 
 
Continuing Education Credit
 
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.100 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must complete the online pre-test (ungraded), watch the included video in its entirety, pass the online post-test ( > 70% within 5 attempts), and complete the online evaluation.  Upon successful completion of the course evaluation, continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 7 days). 
Please make sure NABP profile ID and date of birth (month/year) are entered correctly under learner's profile in this system.
 
 

Fee

$12.00

CE Hours

1.00

CE Units

0.100

Activity Type

Knowledge

Target Audience(s)

Pharmacists

 

Pancreatic Cancer Update
 

Pancreatic Cancer Update

About the Faculty

Scott Soefje, PharmD, MBA, BCOP, FCCP
Director, Pharmacy Cancer Care
Mayo Clinic Assistant Professor of Pharmacy
Mayo Clinic College of Medicine and Science

Scott earned his BS Pharmacy from UT Austin and then after five years of hospital practice, he returned to earn a PharmD from UT Austin. He completed a Specialty Residency in Oncology Pharmacy at the San Antonio VA and a Clinical Pharmacology Fellowship at the M.D. Anderson Cancer Center. He obtained an MBA from George Washington University. He has been Board Certified in Oncology Pharmacy since 2000.

Disclosure:  Scott Soefje has disclosed the following relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence):  Note:  UT CPE mitigated the following financial relationships by having Dr. Soefje's content peer-reviewed prior to the activity by a knowledgeable practitioner who has no relevant financial relationships.  The review ensured the content is valid and free from commercial influence. Pfizer - Speaker's Bureau Merck - Consulting Beigene - Consulting

 

Activity Number

0067-0000-21-149-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.00